Mathematical model of pulsed immunotherapy for superficial bladder cancer

被引:73
|
作者
Bunimovich-Mendrazitsky, Svetlana [1 ]
Byrne, Helen [2 ]
Stone, Lewi [1 ]
机构
[1] Tel Aviv Univ, Fac Life Sci, Dept Zool, Biomath Unit, IL-69978 Tel Aviv, Israel
[2] Ctr Math Med & Biol, Sch Math Sci, Nottingham NG7 2RD, England
关键词
transitional cell carcinoma (TCC); immune response; therapy schedule; impulsive differential equations;
D O I
10.1007/s11538-008-9344-z
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
We present a theoretical study of superficial bladder cancer growth and its treatment via pulsed immunotherapy with Bacillus Calmette-Guerin (BCG), an attenuated strain of Mycobacterium bovis. BCG pulsed immunotherapy is a clinically established procedure for the treatment of superficial bladder cancer. In this paper, periodic BCG instillations are modeled using impulsive differential equations, which are studied using a combination of analytical and numerical techniques. In this way, we determine critical threshold values of the BCG instillation dose and rate of pulsing for successful treatment. We also identify treatment regimes in which tumor destruction occurs, but undesirable side effects are maintained at low levels by the immune system.
引用
收藏
页码:2055 / 2076
页数:22
相关论文
共 50 条
  • [41] Utility of maintenance intravesical immunotherapy in preventing recurrence and progression of superficial bladder cancer
    Iori, F
    Verì, A
    De Nunzio, C
    Mama, A
    Vahedi, M
    Bonginelli, P
    Romiti, A
    Feroci, D
    Lacava, V
    Di Seri, M
    ANNALS OF ONCOLOGY, 2000, 11 : 32 - 32
  • [42] The impact of age on the response of patients with superficial bladder cancer to intravesical immunotherapy - Comment
    Lamm, DL
    JOURNAL OF UROLOGY, 2006, 175 (05): : 1639 - 1640
  • [43] Efficacy and safety of bacille Calmette-Guerin immunotherapy in superficial bladder cancer
    Lamm, DL
    CLINICAL INFECTIOUS DISEASES, 2000, 31 : S86 - S90
  • [44] Immune mechanisms in bacillus Calmette-Guerin immunotherapy for superficial bladder cancer
    Böhle, A
    Brandau, S
    JOURNAL OF UROLOGY, 2003, 170 (03): : 964 - 969
  • [45] A novel immunotherapy for superficial bladder cancer by intravesical immobilization of GM-CSF
    Hu, Zhiming
    Tan, Wanlong
    Zhang, Lin
    Liang, Zhongkun
    Xu, Cuixiang
    Su, Hua
    Lu, Jianxin
    Gao, Jimin
    JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2010, 14 (6B) : 1836 - 1844
  • [46] ANTIBODY DRUG CARRIER FOR IMMUNOTHERAPY OF SUPERFICIAL BLADDER-CANCER - ULTRASTRUCTURAL STUDIES
    DEHARVEN, E
    FRADET, Y
    CONNOLLY, JG
    HANNA, W
    HE, SM
    WANG, YC
    CHOI, BCK
    MCGROARTY, R
    BOOTSMA, G
    TILUPS, A
    CHRISTENSEN, H
    CANCER RESEARCH, 1992, 52 (11) : 3131 - 3137
  • [47] EFFECTS OF LOCAL CHEMOTHERAPY AND IMMUNOTHERAPY ON THE RECURRENCE AND PROGRESSION OF SUPERFICIAL BLADDER-CANCER
    NOVAK, R
    KERN, J
    FISTER, H
    TRNSKI, D
    DIMANOVSKI, J
    KRAUS, O
    EUROPEAN UROLOGY, 1988, 14 (05) : 367 - 370
  • [48] Superficial bladder cancer
    Lamm D.L.
    Current Treatment Options in Oncology, 2002, 3 (5) : 403 - 411
  • [49] A mathematical model of combined bacillus Calmette-Guerin (BCG) and interleukin(IL)-2immunotherapy of superficial bladder cancer (vol 277, pg 27, 2011)
    Bunimovich-Mendrazitsky, Svetlana
    Gluckman, Jean Claude
    Chaskalovic, Joel
    JOURNAL OF THEORETICAL BIOLOGY, 2011, 281 (01) : 140 - 140
  • [50] PERIODICALLY PULSED IMMUNOTHERAPY IN A MATHEMATICAL MODEL OF TUMOR-IMMUNE INTERACTION
    Wei, Hsiu-Chuan
    Lin, Jenn-Tsann
    INTERNATIONAL JOURNAL OF BIFURCATION AND CHAOS, 2013, 23 (04):